Literature DB >> 10843433

Sensitivity to fungal allergens is a risk factor for life-threatening asthma.

P N Black1, A A Udy, S M Brodie.   

Abstract

BACKGROUND: Previous studies have suggested that sensitivity to Alternaria and Cladosporium may be risk factors for life-threatening asthma. We have investigated this by studying the relationship between skin tests for fungal spores and admission to an intensive care unit (ICU) for asthma.
METHODS: Skin prick tests for fungal spores (Alternaria tenuis, Cladosporium cladosporoides, Helminthosporium maydis, and Epicoccum nigrum), cat dander, house-dust mite (Dermatophagoides pteronyssinus), and a seven-grass mix were performed in three groups of patients: patients admitted to an ICU with an attack of asthma; those who had received emergency treatment for asthma but had not been admitted to an ICU, and those who had never required emergency treatment for their asthma.
RESULTS: Twenty of 37 patients (54%) admitted to the ICU had a positive skin test for one or more fungal allergens compared with 15/50 patients (30%) in each of the other groups (P=0.005). The ICU patients were no more likely to have positive skin tests for the grass mix, cat dander, or house-dust mite than the other patients.
CONCLUSIONS: A positive skin test for fungal allergens is a risk factor for admission to an ICU with an acute attack of asthma.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10843433     DOI: 10.1034/j.1398-9995.2000.00293.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  57 in total

1.  Fungal exposure modulates the effect of polymorphisms of chitinases on emergency department visits and hospitalizations.

Authors:  Ann Chen Wu; Jessica Lasky-Su; Christine A Rogers; Barbara J Klanderman; Augusto A Litonjua
Journal:  Am J Respir Crit Care Med       Date:  2010-06-10       Impact factor: 21.405

Review 2.  Management of severe asthma in children.

Authors:  Andrew Bush; Sejal Saglani
Journal:  Lancet       Date:  2010-09-04       Impact factor: 79.321

3.  The influence of Schizophyllum commune on asthma severity.

Authors:  Haruhiko Ogawa; Masaki Fujimura; Yasuo Takeuchi; Koichi Makimura
Journal:  Lung       Date:  2011-10-18       Impact factor: 2.584

Review 4.  Allergens and thunderstorm asthma.

Authors:  Shuaib M Nasser; Thomas B Pulimood
Journal:  Curr Allergy Asthma Rep       Date:  2009-09       Impact factor: 4.806

Review 5.  Severe asthma with fungal sensitization.

Authors:  Ritesh Agarwal
Journal:  Curr Allergy Asthma Rep       Date:  2011-10       Impact factor: 4.806

6.  The link between mold sensitivity and asthma severity in a cohort of northern Chinese patients.

Authors:  Yanliang Ma; Guizhen Tian; Fei Tang; Bing Yu; Yanwen Chen; Yueli Cui; Quanying He; Zhancheng Gao
Journal:  J Thorac Dis       Date:  2015-04       Impact factor: 2.895

7.  Cloning of a gene encoding an Alt a 1 isoallergen differentially expressed by the necrotrophic fungus Alternaria brassicicola during Arabidopsis infection.

Authors:  Robert A Cramer; Christopher B Lawrence
Journal:  Appl Environ Microbiol       Date:  2003-04       Impact factor: 4.792

8.  Association of IL-4RA single nucleotide polymorphisms, HLA-DR and HLA-DQ in children with Alternaria-sensitive moderate-severe asthma.

Authors:  Alan P Knutsen; Hari M Vijay; Barbara Kariuki; Luis A Santiago; Ralph Graff; Jonathan D Wofford; Maulik R Shah
Journal:  Clin Mol Allergy       Date:  2010-03-18

9.  Link between allergic asthma and airway mucosal infection suggested by proteinase-secreting household fungi.

Authors:  P Porter; S C Susarla; S Polikepahad; Y Qian; J Hampton; A Kiss; S Vaidya; S Sur; V Ongeri; T Yang; G L Delclos; S Abramson; F Kheradmand; D B Corry
Journal:  Mucosal Immunol       Date:  2009-08-26       Impact factor: 7.313

Review 10.  Acute exacerbations of asthma: epidemiology, biology and the exacerbation-prone phenotype.

Authors:  R H Dougherty; J V Fahy
Journal:  Clin Exp Allergy       Date:  2009-02       Impact factor: 5.018

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.